0001773751-24-000059.txt : 20240315
0001773751-24-000059.hdr.sgml : 20240315
20240315161246
ACCESSION NUMBER: 0001773751-24-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boughton Soleil
CENTRAL INDEX KEY: 0001837817
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 24754882
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT STREET, #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wk-form4_1710533549.xml
FORM 4
X0508
4
2024-03-13
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001837817
Boughton Soleil
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
0
1
0
0
Chief Legal Officer
1
Class A Common Stock
2024-03-13
4
M
0
63621
2.43
A
217966
D
Class A Common Stock
2024-03-13
4
S
0
63621
15.1682
D
154345
D
Stock Option (right to buy)
2.43
2024-03-13
4
M
0
63621
0
D
2030-05-12
Class A Common Stock
63621
113769
D
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.00 - $15.375. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous service beginning February 12, 2020. 100% of the shares subject to the option have vested.
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
2024-03-15